Table 4 Association between neutrophil–lymphocyte ratio/platelet–lymphocyte ratio, and mortality in 1435 Asian breast cancer patients using different cutoff values
Number of patients | Hazard ratio (95% CI) a | |
|---|---|---|
Neutrophil–lymphocyte ratio | ||
⩽3.00 | 1045 | 1.00 |
>3.00 | 390 | 1.20 (0.99–1.45) |
⩽4.00 | 1241 | 1.00 |
>4.00 | 194 | 1.37 (1.08–1.74)b |
⩽5.00 | 1316 | 1.00 |
>5.00 | 119 | 1.45 (1.08–1.93)b |
Platelet–lymphocyte ratio | ||
⩽185 | 1011 | 1.00 |
>185 | 424 | 1.25 (1.04–1.52)b |
⩽292 | 1302 | 1.00 |
>292 | 133 | 1.30 (0.98–1.70) |
